| Literature DB >> 26493665 |
Carl J Pepine1, Keith C Ferdinand2, Leslee J Shaw3, Kelly Ann Light-McGroary4, Rashmee U Shah5, Martha Gulati6, Claire Duvernoy7, Mary Norine Walsh8, C Noel Bairey Merz9.
Abstract
Recognition of ischemic heart disease (IHD) is often delayed or deferred in women. Thus, many at risk for adverse outcomes are not provided specific diagnostic, preventive, and/or treatment strategies. This lack of recognition is related to sex-specific IHD pathophysiology that differs from traditional models using data from men with flow-limiting coronary artery disease (CAD) obstructions. Symptomatic women are less likely to have obstructive CAD than men with similar symptoms, and tend to have coronary microvascular dysfunction, plaque erosion, and thrombus formation. Emerging data document that more extensive, nonobstructive CAD involvement, hypertension, and diabetes are associated with major adverse events similar to those with obstructive CAD. A central emerging paradigm is the concept of nonobstructive CAD as a cause of IHD and related adverse outcomes among women. This position paper summarizes currently available knowledge and gaps in that knowledge, and recommends management options that could be useful until additional evidence emerges.Entities:
Keywords: adverse outcomes; ischemia; sex-specific pathophysiology
Mesh:
Year: 2015 PMID: 26493665 PMCID: PMC4618799 DOI: 10.1016/j.jacc.2015.08.876
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 24.094